Two pharmaceutical firms to cooperate in developing single-tablet, two-drug treatment for HIV. Clinical studies could begin in 2015.
Two pharmaceutical firms to cooperate in developing single-tablet, two-drug treatment for HIV. Clinical studies could begin in 2015.